CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing bispecific antibodies to enhance cancer treatment by targeting both cancer cells and immune cells. The innovative production method aims to streamline the creation of these antibodies, potentially improving their effectiveness and reducing side effects.
Cancer represents one of the major challenges for modern medicine as we still lack tools to selectively target malignant over healthy tissues.
The main issues with state of the art anti-cancer treatments lie on their inefficiency and their associated side-effects.
Improving this treatments has focused a lot of attention of the scientific community and has led to the development of new strategies.
Harnessing our own immune system to fight malignant cells is one of the strategies with promising p…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
